Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Nonacog alfa in Hemorrhage: NCT04286412 Clinical Landscape Report 2026
16 October 2026
NCT04286412 clinical landscape for Hemorrhage: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Hemopexin (CSL Behring) in Acute Chest Syndrome: NCT04285827 Clinical Landscape Report 2026
16 October 2026
NCT04285827 clinical landscape for Acute Chest Syndrome: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Omega-3-acid ethyl esters(Trygg Pharma AS) in Vaso-occlusive crisis: NCT04301336 Clinical Landscape Report 2026
16 October 2026
NCT04301336 clinical landscape for Vaso-occlusive crisis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Telitacicept in Myasthenia Gravis: NCT04302103 Clinical Landscape Report 2026
16 October 2026
NCT04302103 clinical landscape for Myasthenia Gravis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Ticagrelor in Vaso-occlusive crisis: NCT04293172 Clinical Landscape Report 2026
16 October 2026
NCT04293172 clinical landscape for Vaso-occlusive crisis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Lovotibeglogene autotemcel in Anemia, Sickle Cell: NCT04293185 Clinical Landscape Report 2026
16 October 2026
NCT04293185 clinical landscape for Anemia, Sickle Cell: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Acetylcysteine in Idiopathic Pulmonary Fibrosis: NCT04300920 Clinical Landscape Report 2026
16 October 2026
NCT04300920 clinical landscape for Idiopathic Pulmonary Fibrosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Emicizumab in Hemophilia A: NCT04303572 Clinical Landscape Report 2026
16 October 2026
NCT04303572 clinical landscape for Hemophilia A: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Emicizumab in Hemophilia A: NCT04303559 Clinical Landscape Report 2026
16 October 2026
NCT04303559 clinical landscape for Hemophilia A: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Jaktinib Hydrochloride in Idiopathic Pulmonary Fibrosis: NCT04312594 Clinical Landscape Report 2026
16 October 2026
NCT04312594 clinical landscape for Idiopathic Pulmonary Fibrosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Ifenprodil Tartrate in Cough: NCT04318704 Clinical Landscape Report 2026
16 October 2026
NCT04318704 clinical landscape for Cough: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Admilparant in Idiopathic Pulmonary Fibrosis: NCT04308681 Clinical Landscape Report 2026
16 October 2026
NCT04308681 clinical landscape for Idiopathic Pulmonary Fibrosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.